Cisplatin/70 Gy IMRT Cemented as SOC for Nonsmoking p16+ Oropharyngeal Cancer
The standard schedule of 70 Gy intensity-modulated radiation therapy (IMRT) plus cisplatin was not inferior to a deintensification Gy IMRT schedule or to a regimen using nivolumab (Opdivo) vs cisplatin in patients with p16-positive oropharyngeal cancer, …